HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

Abstract
Immunity against Vibrio cholerae O1 is serogroup specific, and serogrouping is defined by the O-specific polysaccharide (OSP) part of lipopolysaccharide (LPS). Despite this, human immune responses to V. cholerae OSP have not previously been characterized. We assessed immune responses against V. cholerae OSP in adults with cholera caused by V. cholerae O1 El Tor serotype Inaba or Ogawa in Dhaka, Bangladesh, using O1 OSP-core-bovine serum albumin (OSPc:BSA) conjugates; responses targeted OSP in these conjugates. Responses of Inaba-infected patients to Inaba OSP and LPS increased significantly in IgG, IgM, and IgA isotypes from the acute to convalescent phases of illness, and the responses correlated well between OSP and LPS (R = 0.86, 0.73, and 0.91, respectively; P < 0.01). Plasma IgG, IgM, and IgA responses to Ogawa OSP and LPS in Ogawa-infected patients also correlated well with each other (R = 0.60, 0.60, and 0.92, respectively; P < 0.01). Plasma IgM responses to Inaba OSP and Ogawa OSP correlated with the respective serogroup-specific vibriocidal antibodies (R = 0.80 and 0.66, respectively; P < 0.001). Addition of either OSPc:BSA or LPS, but not BSA, to vibriocidal assays inhibited vibriocidal responses in a comparable and concentration-dependent manner. Mucosal IgA immune responses to OSP and LPS were also similar. Our study is the first to characterize anti-OSP immune responses in patients with cholera and suggests that responses targeting V. cholerae LPS, including vibriocidal responses that correlate with protection against cholera, predominantly target OSP. Induction of anti-OSP responses may be associated with protection against cholera, and our results may support the development of a vaccine targeting V. cholerae OSP.
AuthorsRussell A Johnson, Taher Uddin, Amena Aktar, M Mohasin, Mohammad Murshid Alam, Fahima Chowdhury, Jason B Harris, Regina C LaRocque, Meagan Kelly Bufano, Yanan Yu, Ying Wu-Freeman, Daniel T Leung, David Sarracino, Bryan Krastins, Richelle C Charles, Peng Xu, Pavol Kovác, Stephen B Calderwood, Firdausi Qadri, Edward T Ryan
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 19 Issue 11 Pg. 1712-21 (Nov 2012) ISSN: 1556-679X [Electronic] United States
PMID22993410 (Publication Type: Journal Article, Research Support, American Recovery and Reinvestment Act, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • O Antigens
Topics
  • Adult
  • Antibodies, Bacterial (analysis, blood)
  • Bangladesh
  • Blood Bactericidal Activity
  • Cholera (immunology, microbiology)
  • Female
  • Humans
  • Immunity, Mucosal
  • Immunoglobulin A (analysis, blood)
  • Immunoglobulin G (analysis, blood)
  • Immunoglobulin M (analysis, blood)
  • Male
  • O Antigens (immunology)
  • Vibrio cholerae O1 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: